Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

The company had successful launches of its Visium instrument in late 2022 and its new Xenium platform in early 2023. In addition, 10x Genomics defended its intellectual property in 2023 ...

The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...

Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one ...

The Xenium platform includes a versatile and easy-to-use instrument, sensitive and specific chemistry, a diverse menu of customizable panels, and powerful visualization software. 10x Genomics delivers ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

10X Genomics specializes in developing and manufacturing genomics analysis technologies. The company's product portfolio includes the Chromium and Spatial platforms, as well as the Xenium line of ...

Xenium is a powerful in situ gene expression platform designed for spatially resolving RNA transcripts (up to 5,000 genes) within tissue samples. It enables detailed mapping of gene activity at the ...